GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (STU:OJU1) » Definitions » Purchase Of Investment

Oramed Pharmaceuticals (STU:OJU1) Purchase Of Investment : €-47.28 Mil (TTM As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Oramed Pharmaceuticals Purchase Of Investment?

Oramed Pharmaceuticals's purchase of investment for the three months ended in Mar. 2025 was €0.00 Mil. It means Oramed Pharmaceuticals spent €0.00 Mil on purchasing investments. Oramed Pharmaceuticals's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was €-47.28 Mil.

Compared with last quarter (€-11.46 Mil in Dec. 2024 ), Oramed Pharmaceuticals spent less money on purchasing investments in Mar. 2025 (€0.00 Mil).


Oramed Pharmaceuticals Purchase Of Investment Historical Data

The historical data trend for Oramed Pharmaceuticals's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals Purchase Of Investment Chart

Oramed Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.28 -45.75 -145.76 -175.07 -53.25

Oramed Pharmaceuticals Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.68 - -35.82 -11.46 -

Oramed Pharmaceuticals Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-47.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oramed Pharmaceuticals Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Oramed Pharmaceuticals Business Description

Traded in Other Exchanges
Address
1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Oramed Pharmaceuticals Headlines

No Headlines